Masatake Tanaka

7PUBLICATIONS
37CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHumoural immunology and immunochemistryNumerical modelling and mechanical characterisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 12, 2026
Cisterna Chyli Dilation Is a Risk Factor for Liver Nodules and Hepatocellular Carcinoma in Fontan-Associated Liver Disease: Pathophysiological Role of Lymphatic Dysfunction.

|Sep 26, 2025
Advances in Systemic Therapy for Hepatocellular Carcinoma and Future Prospects.

Rie Sugimoto, Miho Kurokawa, Yuki Tanaka

|Aug 09, 2025
Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment.

Eiichi Ogawa, Motoyuki Kohjima, Toshimasa Koyanagi

|Feb 07, 2025
Stratifying and predicting progression to acute liver failure during the early phase of acute liver injury.

Raiki Yoshimura, Masatake Tanaka, Miho Kurokawa

|Feb 03, 2025
Long-Term Liver Morbidity and Mortality After Hepatitis C Virus Elimination by Direct-Acting Antivirals.

Eiichi Ogawa, Akira Kawano, Motoyuki Kohjima

|Jan 27, 2025
Liver Lymphatic Dysfunction as a Driver of Fibrosis and Cirrhosis Progression.

Jain Jeong, Shao-Jung Hsu, Daiki Horikami

Pageof 2

Frequent Collaborators

3 joint publications

Rie Sugimoto

2 joint publications

Takeshi Goya

2 joint publications

Eiichi Ogawa

1 joint publications

Yoshihiro Ogawa